BeautyHealth Poised to Announce Q2 2025 Earnings This Week
The Beauty Health Company (NASDAQ: SKIN), the powerhouse behind the renowned HydraFacial brand, is set to announce its Q2 2025 financial results after the market closes on Thursday, August 7, 2025. This will be followed by an investor conference call at 4:30 p.m. Eastern Time. The company recently celebrated a significant achievement with the installation of over 35,000 HydraFacial devices globally, a testament to the growing consumer demand for clinically proven skin health treatments.
In Q1 2025, BeautyHealth surpassed revenue expectations, reporting a robust $69.6 million, which was above the high end of guidance. The adjusted EBITDA also exceeded $7 million. A key driver of this profitability has been the favorable shift towards high-margin consumables, which saw growth of over 8% and now account for more than 70% of the total revenue. This shift has led to a significant improvement in the company’s adjusted gross margin, which now stands at 71.9%.
For the full year of 2025, BeautyHealth has maintained its sales guidance between $270 million and $300 million. The adjusted EBITDA is projected to be between $15 million and $25 million. The company’s portfolio includes leading brands such as HydraFacial in hydradermabrasion, SkinStylus in microneedling, and Keravive in scalp health. These brands serve millions of skin health experiences annually across a global network of estheticians and partners.
Source: Globe Newswire